Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 2
1984 1
1987 1
1991 2
1993 1
1995 3
1998 5
1999 4
2000 1
2001 1
2002 1
2003 2
2004 1
2006 2
2007 3
2008 2
2009 4
2010 4
2011 3
2013 2
2014 2
2015 2
2016 3
2017 2
2018 2
2020 1
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Ciclesonide and the treatment of asthma.
Korenblat PE. Korenblat PE. Expert Opin Pharmacother. 2010 Feb;11(3):463-79. doi: 10.1517/14656560903575647. Expert Opin Pharmacother. 2010. PMID: 20102309 Review.
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.
Corren J, Szefler SJ, Sher E, Korenblat P, Soong W, Hanania NA, Berman G, Brusselle G, Zitnik R, Natalie CR, Sun L, Siu K, Wu WS, Lio P, Armstrong AW. Corren J, et al. Among authors: korenblat p. J Allergy Clin Immunol Pract. 2024 May;12(5):1215-1224.e3. doi: 10.1016/j.jaip.2024.02.007. Epub 2024 Feb 14. J Allergy Clin Immunol Pract. 2024. PMID: 38360213 Free article. Clinical Trial.
Status asthmaticus.
Senior RM, Lefrak SS, Korenblat PE. Senior RM, et al. Among authors: korenblat pe. JAMA. 1975 Mar 24;231(12):1277-9. JAMA. 1975. PMID: 1172959 No abstract available.
Systemic mastocytosis and osteoporosis.
Chines A, Pacifici R, Avioli LA, Korenblat PE, Teitelbaum SL. Chines A, et al. Among authors: korenblat pe. Osteoporos Int. 1993;3 Suppl 1:147-9. doi: 10.1007/BF01621891. Osteoporos Int. 1993. PMID: 8461544 No abstract available.
The role of antileukotrienes in the treatment of asthma.
Korenblat PE; Antileukotriene Working Group. Korenblat PE, et al. Ann Allergy Asthma Immunol. 2001 Jun;86(6 Suppl 1):31-9. doi: 10.1016/s1081-1206(10)62309-5. Ann Allergy Asthma Immunol. 2001. PMID: 11426914 Review.
58 results